Public Policy: Pharmacy, Medicine & Health Law, Economics, Social Sciences

New Efforts to Help Improve Medical Products for Patient Safety and Quality of Medical Care

HHS Secretary Mike Leavitt today announced efforts underway at the U.S. Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS) that will complement each other to improve patient safety and the quality of medical care....Read More

Care Crisis Looms for Aging Americans

Demographic data indicate that by 2030, 70 million Americans will be 65 years of age or older, a near doubling of the senior population in 2005. As the population ages, its need for health care services is expected to rise dramatically and reshape the nation's medical landscape....Read More

Testimony of Dennis Quaid Before the Committee on Oversight and Government

Actor Dennis Quaid testified to Congress that his family should be able to hold a drug company legally accountable for the near fatal overdose of his twin newborn children....Read More

Experts: Price spike should have raised alarm on heparin

The price of the Chinese-produced main ingredient used to make the bloodthinner heparin doubled last year, just four months before hundreds of American patients began having severe and sometimes fatal allergic reactionsto the medication, according to a report from an authoritative druginformation company in China....Read More

Medicare to tighten rules for private plans

Companies that sell Medicare Advantage plans would have to modify sales commissions to stop salesmen from switching beneficiaries to a new plan each year to earn the highest possible fee, a U.S. government agency proposed on Thursday....Read More

Trying Times at the FDA? The Challenge of Ensuring the Safety of Imported Pharmaceuticals

In recent years, the Food and Drug Administration (FDA) has faced three serious challenges to its ability to ensure the safety of the country's medical devices and drugs. The first arose when the widely marketed drug Vioxx (rofecoxib) was shown to be dangerous enough for its manufacturer to withdraw it from the market....Read More

New Report Spells Out the Critical Health Risk in Adding Human Antibiotics to Animal Feed

The release of a new report by the Pew Commission on Industrial Farm Animal Production, spelling out the public health risk inherent in factory farming, heightens the urgency surrounding the Preservation of Antibiotics for Medical Treatment Act (PAMTA)....Read More

Joint Commission Alert Targets Pediatric Medication Errors

The Joint Commission issued a Sentinel Event Alert on Friday about errors with medications specifically made for adults but administered to children in health care facilities, saying the errors are putting young patients at greater risk....Read More

Better Resources and Additional Funds Sought To Improve Foreign Drug Oversight

Congress is seeking funding for additional federal safety inspectors and for an increase in the policing of overseas suppliers. This moves comes after the influx of contaminated drugs, pet food and toothpaste from China....Read More

Quarter of Disabled Seniors Use Risky Medications

Senior citizens with disabilities are twice as likely as their non-disabled counterparts to being taking at least one prescription drug deemed inappropriate for people 65 or older, according to new research. ...Read More

U.S. hospital ERs overwhelmed, one-day study finds

The report from the House of Representatives Oversight and Government Reform Committee, released to coincide with a hearing on Monday, shows emergency rooms in Washington and Los Angeles operating over capacity on an ordinary day. None could have handled a surge of new patients....Read More

TNFerade: Fight Against Cancer: Patient vs. Process: Why One Cancer Patient Is Fighting a Drug Company Working on a Cure

On this relatively good morning in the course of her mom's inoperable cancer, Jackie Loughman, of Indianapolis, knows some facts about pain that she wishes she didn't. ...Read More